Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema. 2014

Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
Institute for Heart and Lung Health, St. Paul's Hospital, Vancouver, BC.

Alveolar macrophages play an important role in chronic obstructive pulmonary disease via production of matrix metalloproteinases (MMPs) and cathepsins as well as their inhibitors, tissue inhibitors of metalloproteinases and cystatin C. We hypothesised that expression levels of these molecules by alveolar macrophages at baseline and after stimulation would be influenced by genotype and associated with chronic obstructive pulmonary disease phenotypes. Quantitative PCR and ELISAs/gelatine zymography were used to investigate expression levels of mRNA and protein, respectively. The relationships of expression with genotype, pulmonary function and emphysema were analysed. The results showed that basal expression level of MMP12 mRNA was inversely related to the diffusing capacity of the lung for carbon monoxide/alveolar volume and to forced expiratory volume in 1 s/forced vital capacity after correction for multiple comparisons. The expression level of MMP12 protein stimulated with lipopolysaccharide was also inversely related to the diffusing capacity of the lung for carbon monoxide/alveolar volume and was positively related to the extent of emphysema. The basal expression of MMP1 mRNA was positively correlated with the extent of emphysema. Cathepsin L protein level was positively associated with forced expiratory volume in 1 s % predicted. We conclude that increased MMP12 and MMP1 expression may play a role in the pathogenesis of emphysema. Cathepsin L and MMP9 may be involved in the development of airflow limitation.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011653 Pulmonary Diffusing Capacity The amount of a gas taken up, by the pulmonary capillary blood from the alveolar gas, per minute per unit of average pressure of the gradient of the gas across the BLOOD-AIR BARRIER. Capacity, Pulmonary Diffusing,Diffusing Capacity, Pulmonary
D011656 Pulmonary Emphysema Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions. Emphysema, Pulmonary,Centriacinar Emphysema,Centrilobular Emphysema,Emphysemas, Pulmonary,Focal Emphysema,Panacinar Emphysema,Panlobular Emphysema,Pulmonary Emphysemas,Centriacinar Emphysemas,Centrilobular Emphysemas,Emphysema, Centriacinar,Emphysema, Centrilobular,Emphysema, Focal,Emphysema, Panacinar,Emphysema, Panlobular,Emphysemas, Centriacinar,Emphysemas, Centrilobular,Emphysemas, Focal,Emphysemas, Panacinar,Emphysemas, Panlobular,Focal Emphysemas,Panacinar Emphysemas,Panlobular Emphysemas
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
January 1999, Histology and histopathology,
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
February 1987, Clinical science (London, England : 1979),
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
February 1976, The American review of respiratory disease,
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
April 1994, American journal of respiratory and critical care medicine,
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
August 1981, Immunology today,
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
June 1997, Respirology (Carlton, Vic.),
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
May 1998, Chest,
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
January 1991, Cancer detection and prevention,
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
December 1996, Australian and New Zealand journal of medicine,
Takeo Ishii, and Raja T Abboud, and Alison M Wallace, and John C English, and Harvey O Coxson, and Richard J Finley, and Karey Shumansky, and Peter D Paré, and Andrew J Sandford
May 1990, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!